DCBLD2 anticorps

N° du produit ABIN7236782

Cet anticorps anti-DCBLD2 Polyclonal Lapin (ABIN7236782) détecte spécifiquement DCBLD2 dans ELISA et IHC. L’anticorps est réactif avec des échantillons de Humain, Souris et Rat.

Aperçu rapide pour DCBLD2 anticorps (ABIN7236782)

Antigène: DCBLD2 (Discoidin, CUB and LCCL Domain Containing 2 (DCBLD2))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp DCBLD2 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Détail du produit anti-DCBLD2 anticorps

Attributs du produit: Polyclonal Antibody

Purification: Affinity purification

Immunogène: Recombinant protein of human DCBLD2

Isotype: IgG

Information d'application

Indications d'application: IHC 1:100-1:300

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur DCBLD2

Antigène: DCBLD2 (Discoidin, CUB and LCCL Domain Containing 2 (DCBLD2))

Autre désignation: DCBLD2

Sujet: CLCP1 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1), also known as DCBLD2 (discoidin, CUB and LCCL domain containing 2) or ESDN, is a 775 amino acid single-pass type I membrane protein that contains one CUB domain, one LCCL domain and one F5/8 type C domain. Expressed at high levels in heart, testis and skeletal muscle, CLCP1 is thought to regulate vascular smooth muscle cell (VSMC) proliferation and remodeling and may be involved in the transformation and metastasis of various cancers, such as metastatic lung cancer and gastric carcinoma.

UniProt: Q96PD2